In a statement, the company said the Breztri approval means the device is now approved for use with all triple-therapy inhalers ... that the global market for smart inhaler devices that enable ...

When you have moderate to severe disease, you and your doctor will work together to find the right therapy for you. Although there's no cure for COPD, devices like Inhaler, portable oxygen and ...

The prevalence of respiratory disorders is rising due to factors such as air pollution, smoking, and an aging population. According to the World Health Organization (WHO), COPD is projected to become ...

Novartis managed to get the UK to agree to a “smart deal” on pricing for its CAR-T cancer cell therapy Kymriah, meaning patients in the country were the first to get access outside of the US.